150 related articles for article (PubMed ID: 9856663)
1. Strontium-89 (89Sr) analgesia for rare thymic carcinoid tumor with bony metastases.
Vishne TH; Ron IG
Am J Clin Oncol; 1998 Dec; 21(6):602-4. PubMed ID: 9856663
[TBL] [Abstract][Full Text] [Related]
2. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
[TBL] [Abstract][Full Text] [Related]
3. Systemic radionuclide therapy in pain palliation.
Liepe K; Runge R; Kotzerke J
Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
[TBL] [Abstract][Full Text] [Related]
4. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
5. Strontium-89 chloride in the treatment of bone metastases from breast cancer.
Baziotis N; Yakoumakis E; Zissimopoulos A; Geronicola-Trapali X; Malamitsi J; Proukakis C
Oncology; 1998; 55(5):377-81. PubMed ID: 9732212
[TBL] [Abstract][Full Text] [Related]
6. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
[TBL] [Abstract][Full Text] [Related]
7. [Use of strontium-89 in the analgesic treatment of bone metastases].
Hayek D; Ritschard J; Zwahlen A; Courvoisier B; Donath A
Schweiz Med Wochenschr; 1980 Aug; 110(31-32):1154-9. PubMed ID: 7444409
[TBL] [Abstract][Full Text] [Related]
8. Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain.
Berna L; Carrio I; Alonso C; Ferré J; Estorch M; Torres G
Eur J Nucl Med; 1995 Oct; 22(10):1101-4. PubMed ID: 8542891
[TBL] [Abstract][Full Text] [Related]
9. The correlation between palliation of bone pain by intravenous strontium-89 and external beam radiation to linked field in patients with osteoblastic bone metastases.
Ron IG; Stav O; Vishne T; Evan-Sapir E; Soyfer V; Agai R; Cherny N; Kovner F
Am J Clin Oncol; 2004 Oct; 27(5):500-4. PubMed ID: 15596920
[TBL] [Abstract][Full Text] [Related]
10. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
Dafermou A; Colamussi P; Giganti M; Cittanti C; Bestagno M; Piffanelli A
Eur J Nucl Med; 2001 Jul; 28(7):788-98. PubMed ID: 11504074
[TBL] [Abstract][Full Text] [Related]
11. [Strontium-89 therapy and subarachnoid phenol block successfully eliminated intractable pain of metastasis in the patient with advanced urachal carcinoma].
Arakawa Y; Inoue D; Sakuyama T; Nagasaki E; Aiba K
Gan To Kagaku Ryoho; 2011 Dec; 38 Suppl 1():59-60. PubMed ID: 22189321
[TBL] [Abstract][Full Text] [Related]
12. [89Sr Therapy for pain relief in patients with bone metastases].
Koizumi K; Arbab AS; Toyama K; Shirasu M; Osawa S; Araki T; Yamaguchi M; Onishi H; Araki T; Arai T; Komatsu H; Ueno A; Nokata H
Kaku Igaku; 1996 Nov; 33(11):1243-8. PubMed ID: 8986064
[TBL] [Abstract][Full Text] [Related]
13. [Strontium chloride (89Sr-chloride) fractional injection method for bone metastases treatment].
Fomin DK; Smirnov IuN; Tararukhina OB; Nazarov AA
Vopr Onkol; 2012; 58(1):116-8. PubMed ID: 22629840
[TBL] [Abstract][Full Text] [Related]
14. [Radioactive strontium for treating incurable pain in skeletal neoplasms (author's transl)].
Firusian N; Schmidt CG
Dtsch Med Wochenschr; 1973 Dec; 98(49):2347-51. PubMed ID: 4763877
[No Abstract] [Full Text] [Related]
15. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
Nair N
J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
[TBL] [Abstract][Full Text] [Related]
16. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
17. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
[TBL] [Abstract][Full Text] [Related]
18. Discrepancy between clinical symptoms and Tc-99m MDP bone scan findings before and after strontium-89 therapy for metastatic bone pain of prostate carcinoma.
Sun SS; Tsai SC; Hsieh JF; Lee JK; Kao CH
Clin Nucl Med; 2001 Feb; 26(2):167-9. PubMed ID: 11201488
[No Abstract] [Full Text] [Related]
19. Systemic radionuclide therapy with strontium chloride Sr 89 for painful skeletal metastases in prostate and breast cancer.
Patel BR; Flowers WM
South Med J; 1997 May; 90(5):506-8. PubMed ID: 9160068
[TBL] [Abstract][Full Text] [Related]
20. 89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes.
Fosså SD; Paus E; Lochoff M; Backe SM; Aas M
Br J Cancer; 1992 Jul; 66(1):177-80. PubMed ID: 1379058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
